These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23291939)

  • 1. Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease.
    Higa LH; Corral RS; Morilla MJ; Romero EL; Petray PB
    Hum Vaccin Immunother; 2013 Feb; 9(2):409-12. PubMed ID: 23291939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.
    Gonzalez RO; Higa LH; Cutrullis RA; Bilen M; Morelli I; Roncaglia DI; Corral RS; Morilla MJ; Petray PB; Romero EL
    BMC Biotechnol; 2009 Aug; 9():71. PubMed ID: 19678953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
    Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ
    PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
    Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
    Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
    Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ; Wrightsman RA; Manning JE
    Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
    Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.
    Matos MN; Cazorla SI; Bivona AE; Morales C; Guzmán CA; Malchiodi EL
    Infect Immun; 2014 Oct; 82(10):4265-75. PubMed ID: 25069980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
    Serna C; Lara JA; Rodrigues SP; Marques AF; Almeida IC; Maldonado RA
    Vaccine; 2014 Jun; 32(28):3525-32. PubMed ID: 24793944
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 20. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.